Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma (original) (raw)

Abstract

Immunohistochemical, cytochemical and ultrastructural data showing vivid angiogenesis and numerous mast cells (MCs) in the bone marrow of 24 patients with active multiple myeloma (MM) compared with 34 patients with non-active MM and 22 patients with monoclonal gammopathy of undetermined significance (MGUS) led us to hypothesize that angiogenesis parallels progression of MM, and that MCs participate in its induction via angiogenic factors in their secretory granules. © 1999 Cancer Research Campaign

Keywords: angiogenesis, mast cell, multiple myeloma, tumour progression

Full Text

The Full Text of this article is available as a PDF (293.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aznavoorian S., Murphy A. N., Stetler-Stevenson W. G., Liotta L. A. Molecular aspects of tumor cell invasion and metastasis. Cancer. 1993 Feb 15;71(4):1368–1383. doi: 10.1002/1097-0142(19930215)71:4<1368::aid-cncr2820710432>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  2. Beil W. J., Login G. R., Galli S. J., Dvorak A. M. Ultrastructural immunogold localization of tumor necrosis factor-alpha to the cytoplasmic granules of rat peritoneal mast cells with rapid microwave fixation. J Allergy Clin Immunol. 1994 Sep;94(3 Pt 1):531–536. doi: 10.1016/0091-6749(94)90210-0. [DOI] [PubMed] [Google Scholar]
  3. Blair R. J., Meng H., Marchese M. J., Ren S., Schwartz L. B., Tonnesen M. G., Gruber B. L. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest. 1997 Jun 1;99(11):2691–2700. doi: 10.1172/JCI119458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bussolino F., Ziche M., Wang J. M., Alessi D., Morbidelli L., Cremona O., Bosia A., Marchisio P. C., Mantovani A. In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest. 1991 Mar;87(3):986–995. doi: 10.1172/JCI115107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Castellot J. J., Jr, Karnovsky M. J., Spiegelman B. M. Differentiation-dependent stimulation of neovascularization and endothelial cell chemotaxis by 3T3 adipocytes. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5597–5601. doi: 10.1073/pnas.79.18.5597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cozzolino F., Torcia M., Aldinucci D., Rubartelli A., Miliani A., Shaw A. R., Lansdorp P. M., Di Guglielmo R. Production of interleukin-1 by bone marrow myeloma cells. Blood. 1989 Jul;74(1):380–387. [PubMed] [Google Scholar]
  7. Dethlefsen S. M., Matsuura N., Zetter B. R. Mast cell accumulation at sites of murine tumor implantation: implications for angiogenesis and tumor metastasis. Invasion Metastasis. 1994;14(1-6):395–408. [PubMed] [Google Scholar]
  8. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med. 1995 Dec 28;333(26):1757–1763. doi: 10.1056/NEJM199512283332608. [DOI] [PubMed] [Google Scholar]
  9. Gruber B. L., Marchese M. J., Kew R. Angiogenic factors stimulate mast-cell migration. Blood. 1995 Oct 1;86(7):2488–2493. [PubMed] [Google Scholar]
  10. Hamada J., Cavanaugh P. G., Lotan O., Nicolson G. L. Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis. Br J Cancer. 1992 Aug;66(2):349–354. doi: 10.1038/bjc.1992.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996 Aug 9;86(3):353–364. doi: 10.1016/s0092-8674(00)80108-7. [DOI] [PubMed] [Google Scholar]
  12. Jakobson A. M., Hahnenberger R. Antiangiogenic effect of heparin and other sulphated glycosaminoglycans in the chick embryo chorioallantoic membrane. Pharmacol Toxicol. 1991 Aug;69(2):122–126. doi: 10.1111/j.1600-0773.1991.tb01284.x. [DOI] [PubMed] [Google Scholar]
  13. Kessler D. A., Langer R. S., Pless N. A., Folkman J. Mast cells and tumor angiogenesis. Int J Cancer. 1976 Nov 15;18(5):703–709. doi: 10.1002/ijc.2910180520. [DOI] [PubMed] [Google Scholar]
  14. Kops S. K., Van Loveren H., Rosenstein R. W., Ptak W., Askenase P. W. Mast cell activation and vascular alterations in immediate hypersensitivity-like reactions induced by a T cell-derived antigen-binding factor. Lab Invest. 1984 Apr;50(4):421–434. [PubMed] [Google Scholar]
  15. Lichtenstein A., Berenson J., Norman D., Chang M. P., Carlile A. Production of cytokines by bone marrow cells obtained from patients with multiple myeloma. Blood. 1989 Sep;74(4):1266–1273. [PubMed] [Google Scholar]
  16. Mignatti P., Rifkin D. B. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev. 1993 Jan;73(1):161–195. doi: 10.1152/physrev.1993.73.1.161. [DOI] [PubMed] [Google Scholar]
  17. Miles S. A., Rezai A. R., Salazar-González J. F., Vander Meyden M., Stevens R. H., Logan D. M., Mitsuyasu R. T., Taga T., Hirano T., Kishimoto T. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4068–4072. doi: 10.1073/pnas.87.11.4068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nakamura M., Merchav S., Carter A., Ernst T. J., Demetri G. D., Furukawa Y., Anderson K., Freedman A. S., Griffin J. D. Expression of a novel 3.5-kb macrophage colony-stimulating factor transcript in human myeloma cells. J Immunol. 1989 Dec 1;143(11):3543–3547. [PubMed] [Google Scholar]
  19. Norrby K. Interleukin-8 and de novo mammalian angiogenesis. Cell Prolif. 1996 Jun;29(6):315–323. doi: 10.1111/j.1365-2184.1996.tb01583.x. [DOI] [PubMed] [Google Scholar]
  20. Polverini P. J. How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases. Eur J Cancer. 1996 Dec;32A(14):2430–2437. doi: 10.1016/s0959-8049(96)00386-3. [DOI] [PubMed] [Google Scholar]
  21. Poole T. J., Zetter B. R. Stimulation of rat peritoneal mast cell migration by tumor-derived peptides. Cancer Res. 1983 Dec;43(12 Pt 1):5857–5861. [PubMed] [Google Scholar]
  22. Qu Z., Liebler J. M., Powers M. R., Galey T., Ahmadi P., Huang X. N., Ansel J. C., Butterfield J. H., Planck S. R., Rosenbaum J. T. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol. 1995 Sep;147(3):564–573. [PMC free article] [PubMed] [Google Scholar]
  23. Raju K. S., Alessandri G., Gullino P. M. Characterization of a chemoattractant for endothelium induced by angiogenesis effectors. Cancer Res. 1984 Apr;44(4):1579–1584. [PubMed] [Google Scholar]
  24. Ribatti D., Contino R., Tursi A. Do mast cells intervene in the vasoproliferative process of the rheumatoid synovitis? J Submicrosc Cytol Pathol. 1988 Jul;20(3):635–637. [PubMed] [Google Scholar]
  25. Ribatti D., Nico B., Vacca A., Marzullo A., Calvi N., Roncali L., Dammacco F. Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas? Br J Cancer. 1998 Jun;77(11):1900–1906. doi: 10.1038/bjc.1998.316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ribatti D., Roncali L., Nico B., Bertossi M. Effects of exogenous heparin on the vasculogenesis of the chorioallantoic membrane. Acta Anat (Basel) 1987;130(3):257–263. doi: 10.1159/000146454. [DOI] [PubMed] [Google Scholar]
  27. Roberts A. B., Sporn M. B., Assoian R. K., Smith J. M., Roche N. S., Wakefield L. M., Heine U. I., Liotta L. A., Falanga V., Kehrl J. H. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4167–4171. doi: 10.1073/pnas.83.12.4167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Schwab G., Siegall C. B., Aarden L. A., Neckers L. M., Nordan R. P. Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266. Blood. 1991 Feb 1;77(3):587–593. [PubMed] [Google Scholar]
  29. Taylor S., Folkman J. Protamine is an inhibitor of angiogenesis. Nature. 1982 May 27;297(5864):307–312. doi: 10.1038/297307a0. [DOI] [PubMed] [Google Scholar]
  30. Thornton S. C., Mueller S. N., Levine E. M. Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science. 1983 Nov 11;222(4624):623–625. doi: 10.1126/science.6635659. [DOI] [PubMed] [Google Scholar]
  31. Vacca A., Moretti S., Ribatti D., Pellegrino A., Pimpinelli N., Bianchi B., Bonifazi E., Ria R., Serio G., Dammacco F. Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9. Eur J Cancer. 1997 Sep;33(10):1685–1692. doi: 10.1016/s0959-8049(97)00186-x. [DOI] [PubMed] [Google Scholar]
  32. Vacca A., Ribatti D., Roncali L., Ranieri G., Serio G., Silvestris F., Dammacco F. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol. 1994 Jul;87(3):503–508. doi: 10.1111/j.1365-2141.1994.tb08304.x. [DOI] [PubMed] [Google Scholar]